SCHEMBL30910089

SCHEMBL30910089

CC(C)N1CCN(C(=O)CCN2CCCCC2)c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
KMT2A Q03164 5/20 0.46
GFER P55789 1/20 0.45
POLB P06746 2/20 0.43
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
MAPT P10636 2/20 0.41
TP53 P04637 1/20 0.41
THRB P10828 1/20 0.41
HTT P42858 1/20 0.41
HSP90AA1 P07900 1/20 0.41
TSHR P16473 1/20 0.40
LMNA P02545 1/20 0.40
NOTUM Q6P988 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SIGMAR1 Q99720 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26088422 1.00 ALDH1A1 (0.46) ALDH1A1KMT2AGFERPOLBDRD2
SCHEMBL26089229 0.99 ALDH1A1 (0.43) ALDH1A1KMT2AGFERPOLBDRD2
SCHEMBL30379221 0.99 ALDH1A1 (0.43) ALDH1A1KMT2AGFERPOLBDRD2
SCHEMBL26088435 0.90 DRD2 (0.47) ALDH1A1KMT2APOLBDRD2DRD4
SCHEMBL30379351 0.90 DRD2 (0.47) ALDH1A1KMT2APOLBDRD2DRD4
SCHEMBL26091237 0.87 ALDH1A1 (0.52) ALDH1A1KMT2APOLBDRD2DRD4
SCHEMBL30910069 0.87 ALDH1A1 (0.52) ALDH1A1KMT2APOLBDRD2DRD4
SCHEMBL30379233 0.84 ALDH1A1 (0.44) ALDH1A1KMT2AGFERPOLBDRD2
SCHEMBL26089134 0.84 ALDH1A1 (0.44) ALDH1A1KMT2AGFERPOLBDRD2
SCHEMBL30910043 0.84 ALDH1A1 (0.45) ALDH1A1KMT2AGFERPOLBDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250002464-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME SAPIENSBIO INC. (KR) 2025-01-02 US claimed
EP-4421070-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Sapiensbio Inc. (KR) 2024-08-28 EP claimed
CN-118119612-A Novel compounds and pharmaceutical compositions comprising the same 萨皮恩斯生物有限公司 2024-05-31 CN claimed
US-20250002464-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME SAPIENSBIO INC. (KR) 2025-01-02 US disclosed
EP-4421070-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Sapiensbio Inc. (KR) 2024-08-28 EP disclosed
CN-118119612-A Novel compounds and pharmaceutical compositions comprising the same 萨皮恩斯生物有限公司 2024-05-31 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250002464-A1 NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME RHOA, ACTR2, MFAP1 ALDH1A1 2159/4885KMT2A 3762/4885GFER 2093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.